Oct 9, 2026
•
4 min read
A new monthly injection changes access to olanzapine. Its use still depends on response, tolerability and informed consent.
Prescribing
Oct 8, 2026
3 min read
An old maintenance prescription does not settle the next dose after an interruption.
Clinical Decisions
Oct 7, 2026
For severe depression, the treatment discussion needs to account for what may happen while another option is being tried.
Clinical Evidence
Oct 6, 2026
A nightmare response deserves recognition while broader PTSD treatment stays active.
Clinical Assessment
Oct 5, 2026
Functional burden belongs in the treatment conversation, even when observed movements seem mild.
Recovery & Function
Oct 2, 2026
5 min read
Eligibility for employment support and fitness for a particular job are different questions. "Not ready" needs a definition.
Oct 1, 2026
Recognizing a medication effect is the beginning of an assessment, not permission to stop asking questions.
Practice Operations
Sep 30, 2026
Payment status, policy applicability and payment accuracy are three different questions.
Sep 29, 2026
6 min read
A small MRI biofeedback trial illustrates why losing statistical significance does not establish fading benefit, and why an early mood signal still needs a convincing explanation.
